CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Washington, DC
Medstar Washington Hospital Center Medical Imaging School & Diagnostic Radiology 110 Irving St NW, WashingtonThis program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.